Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06526052 · ClinicalTrials.gov registry record · NA

A Randomized Controlled Trial Testing the Effect of the Youth Mindful Awareness Program on Negative Affect (YMAP2).

A NA study of Prevention and Control, sponsored by Vanderbilt University.

Recruiting
Registry status
NA
Development phase
360
Enrollment target
3
Study locations

NCT06526052: Recruiting NA study of Prevention and Control, sponsored by Vanderbilt University.

NCT06526052 is a NA study of Prevention and Control that is actively recruiting participants, run by Vanderbilt University. The registered enrollment target is 360 participants, below the 49,960-participant average among 11 other Prevention trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06526052, a NA study of Prevention and Control, is actively recruiting participants, sponsored by Vanderbilt University.

RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
3
Study locations

Study Summary

The goal of this randomized clinical trial is to compare the effects of an online mindfulness program to an active supportive comparison condition and a no-intervention control group on reducing and preventing mood and anxiety symptoms in at-risk youth. Youth who are high on trait negative affect will be randomized to one of the three conditions. The primary outcomes of interest are reductions in momentary negative affect and internalizing problems in adolescents ages 12 to 17 years old. All participants will be evaluated prior to being randomized, after the 9-session intervention period, and at a 6-month follow-up. The first hypothesis is that the mindfulness intervention will predict decreases in stressor-reactive momentary negative affect and internalizing symptoms. The second hypothesis is that changes in momentary negative affect will partially account for the effects of the mindfulness intervention on internalizing symptoms.

Primary Outcome

EMA involves assessments four times a day for 7 days. The measures of momentray negative affect (mNA) from the EMA are Stressor-Independent (mNA-SI), Stressor-Reactive (mNA-SR), and average mNA.

Conditions Studied

Interventions

  • BEHAVIORAL Mindfulness Program
  • BEHAVIORAL Active Comparator

Study Locations (3)

California

  • University of California, Los Angeles - Los Angeles

Illinois

  • Northwestern University - Evanston

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2024-04-01
Est. Completion 2027-04
Phase NA
Vanderbilt University

430 total trials

What NCT06526052 shows while recruiting

NCT06526052 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 49,960-participant average among 11 other Prevention trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Prevention appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness Program is the first listed.

NCT06526052 reports a single indexed study location in California, Illinois, Tennessee.

Frequently Asked Questions

What is clinical trial NCT06526052 about?

NCT06526052 is a clinical study titled "A Randomized Controlled Trial Testing the Effect of the Youth Mindful Awareness Program on Negative Affect (YMAP2).". The goal of this randomized clinical trial is to compare the effects of an online mindfulness program to an active supportive comparison condition and a no-intervention control group on reducing and preventing mood and anxiety symptoms in at-risk youth. Youth who are high on trait negative affect wi...

What is the current status of trial NCT06526052?

This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2024-04-01. Estimated completion is 2027-04.

What conditions does trial NCT06526052 study?

This clinical trial studies the following conditions: Prevention, Control.

What interventions are being tested in trial NCT06526052?

The interventions under investigation include: Mindfulness Program (BEHAVIORAL), Active Comparator (BEHAVIORAL).

Who is sponsoring clinical trial NCT06526052?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06526052 being conducted?

This trial has 3 study locations across California, Illinois, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06526052's enrollment target sits among peer trials

360 6th of 11 higher than 6 of 11 other Prevention trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02747836 · 360 participants

    Ultrasound Analysis of Human Carpal Tunnel System

  • NCT04089046 · 360 participants · NA

    Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)

  • NCT04130503 · 360 participants · NA

    The Recovery in Stroke Using PAP Study

  • NCT04160000 · 360 participants · Phase 4

    Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06526052, the US trial registry maintained by the National Library of Medicine. NCT06526052 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.